MOBERG PHARMA AND PALADIN EXTENDS AGREEMENT FOR KERASAL NAIL™ TO MEXICO
Moberg Pharma AB (OMX: MOB) today announced that Paladin has been granted the exclusive rights to market and sell Kerasal Nail™ in Mexico. Kerasal Nail™ is an over-the-counter (OTC), topical product with a unique mechanism of action that generates visible improvements within 2-4 weeks of treatment. Further details or financial terms of the transaction were not disclosed."We are impressed by the resources Paladin are engaging in the forthcoming product launch in Canada and look forward to extend our collaboration. Mexico is a large and growing market and we expect Kerasal Nail™ to be equally